Funded by the European Union
Department of Biotechnology Government of India

PRESCRIP-TEC last General Assembly in Utrecht

The PRESCRIP-TEC consortium gathered in Utrecht, Netherlands, from 22-25 March, 2023. Representatives from all the participating countries attended with the aim to exchange experiences and information on the project’s progress, ongoing activities, and various work packages. The meeting also served as a platform to prepare for the project’s final stages.

On the first day, the consortium had the opportunity to participate in the 13th European Congress on Tropical Medicine and International Health (ECTMIH2023), also in Utrecht. Themed “Shaping the future of equitable and sustainable planetary health”, the event attracted over 1500 global experts.

PRESCRIP-TEC organised a workshop titled “Innovating cervical cancer screening in low- and middle-income countries and vulnerable groups in Europe”. The session focused on evaluating the feasibility of the World Health Organisation’s strategy for eliminating cervical cancer as a public health problem. Colleagues from PRESCRIP-TEC shared insights into increasing the adoption of cervical cancer screening in resource-poor or hard-to-reach areas, drawing on their experiences in Bangladesh, India, Uganda, and Slovakia.

Moving on to the consortium meeting, plenary sessions were dedicated to preparing scientific publications. In-depth discussions covered various topics, including the analysis of data collected on costs, models used for cost-effectiveness, and progress in the different countries. The day proved inspiring and productive, with fruitful discussions on research questions, protocols,time planning, post-project continuation of activities, and research publications.

On the final day, working teams were established to address concrete actions for final deliverables. Steps were taken to ensure project sustainability and outreach to key leaders and stakeholders who could take the findings of the research forward to impact elimination of cervical cancer in their countries. Participants expressed their satisfaction with the extensive work accomplished in this three-year research and the exchange of knowledge and experiences.

We would like to extend our heartfelt gratitude to all our partners for their unwavering commitment and exceptional contributions to the project’s execution. The meeting in Utrecht stands as a testament to the collaborative efforts of the consortium, symbolising the culmination of years of dedicated work towards advancing cervical cancer screening in diverse and challenging settings.